A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Effectiveness of smoking cessation therapies: a systematic review and meta-analysisAntidepressants for smoking cessationInterventions for preventing weight gain after smoking cessationInterventions for preventing weight gain after smoking cessationAntidepressants for smoking cessationAntidepressants for smoking cessationAdult tobacco use levels after intensive tobacco control measures: New York City, 2002-2003Mirtazapine to reduce methamphetamine use: a randomized controlled trialA systematic review of the relationships between craving and smoking cessationCombination treatment for nicotine dependence: state of the science.A smoking-cessation program consisting of extensive counseling, pharmacotherapy, and office spirometry: results of a pilot project in a Veterans Administration Medical Center.Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Smoking cessation pharmacotherapy preferences in rural primary care.Transplacental transfer and metabolism of bupropion.Psychological mediators of bupropion sustained-release treatment for smoking cessationDo point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic reviewThe association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients.Bupropion: pharmacology and therapeutic applications.Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.The use of bupropion SR in cigarette smoking cessationDifferences in Substance Abuse Counselors' Knowledge of Tobacco Cessation Medication Effectiveness: 2002-2008.Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapiesPharmacogenetics and nicotine addiction treatment.Bupropion and cognitive-behavioral treatment for depression in smoking cessationDrugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Bupropion for the treatment of nicotine withdrawal and craving.Cost effectiveness analysis of smoking cessation interventions.Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinenceWhich is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?Identification of pharmacogenetic markers in smoking cessation therapy.Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature.Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
P2860
Q21093272-0A374082-DE88-4F6C-92CD-A9C66DA0A967Q21093304-3CB64219-4FF2-4662-9199-9EA34A68E4C6Q24201167-9FE5085D-83FA-43A3-BC40-083F8EF6E7AFQ24203883-E80FB42D-8DF6-42EE-BE47-E300D139CDE2Q24241751-11B348CA-6FBF-4E7E-ADA1-38CCE0B1092DQ24245969-D5462E05-75B1-4987-ABE5-E4C4D70B232CQ24246426-9602FCA2-AEC8-4BD1-8E05-69865E40A133Q24544856-915104F2-2DA1-482D-AEB2-55A966DD6322Q24603456-D8E7F6CB-4749-4A8F-B925-2C78F3CE63F9Q27026417-E9C6F605-DABD-4D89-999D-0A1377CE4EC1Q30436150-BD52DF9C-56D4-414C-AA7C-9D8EAE1BB120Q33210517-7C0FCC00-246C-49E3-8167-71CE276C025DQ33351611-7C1330DE-C351-405C-9781-387ACD8DF5E3Q33582063-1BA3A32E-2335-46A0-A2FE-4CE551350659Q33650048-FDB135C2-27E7-41EF-A784-028A6B566C80Q33862465-32D867DB-891A-4016-9483-E28F97D834F6Q33887773-3B0E37C4-1BA5-4100-8765-94B7723F5290Q33945774-CCC98D3A-34A7-42EE-8652-B72D62B86751Q34081684-9B7605FA-57AF-4388-B6E6-6E3DC9AB090DQ34569990-7397DCFF-3332-445C-B5A9-22A2D0ED6038Q34602596-2C183A02-FBC6-405A-B8B5-DE5DAB2D3160Q34779470-3CE8AFB8-05B0-40C9-81A5-BB5F207ACE6CQ34967022-0D48C430-2326-43B6-9815-07DFC73586E7Q34982402-FA865585-11AD-405A-A9EF-3B6EB7F7255AQ35057288-6AC56136-5F1B-492C-B073-CEFC8B79C829Q35523164-6657F5DA-A0F9-47A5-9D80-E505238218CCQ35545542-32C793B0-FB91-4548-BBF1-8B6EFCE33035Q35694111-FEBAE310-8BDE-48A4-8492-62943ABC831BQ36192658-7B4F832A-193B-4D8C-9B3B-EC7D8F971B6DQ36404616-15E51FE3-00C4-49A4-B6B0-25849BF8953FQ36511661-2A2E5737-6FF3-4A54-B566-2F67848B8A78Q36532139-1C6D442B-75AF-4AC1-9626-33F700971EEFQ36638298-F06BB962-580D-40D6-A4DE-06E122CE3F34Q36857811-711E66DB-6F68-4B9A-BC56-73C3B143663CQ36868963-76B16BBC-A8B5-4A33-8DDF-7D496860663DQ36960396-31EBDB21-6E2B-47CD-9530-9F88A36C7802Q37000723-08079632-98FA-40C3-8DC1-6E03A2AACE0BQ37127185-E5F69D97-20FC-479A-B418-19160510EC86Q37164723-08EBE047-8B6D-49D1-A77A-4D45DC150804Q37167372-33BB76D2-8A9E-4201-AA7D-1468ABD5E371
P2860
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@ast
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@en
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@nl
type
label
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@ast
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@en
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@nl
prefLabel
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@ast
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@en
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@nl
P2093
P2860
P1476
A multicentre, randomized, dou ...... pion SR for smoking cessation.
@en
P2093
Hjalmarson A
Townsend J
Tønnesen P
Van Spiegel PI
P2860
P304
P356
10.1046/J.1365-2796.2003.01185.X
P407
P577
2003-08-01T00:00:00Z